KING PHARMACEUTICALS INC 4
4 · KING PHARMACEUTICALS INC · Filed Oct 4, 2006
Insider Transaction Report
Form 4
GREETHAM ELIZABETH M
Director
Transactions
- Award
Common Stock
2006-10-02+1,177→ 6,927 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, with a restricted period that ends on the first to occur of the following events: (1) April 28, 2007; (2) the director, standing for reelection, is not reelected; (3) the director completes his or her term of office after declining to stand for reelection; (4) the director completes his or her term of office after not being nominated to stand for reelection; (5) the director completes his or her term of office, having been ineligible to stand for reelection under term limit provisions then in effect. The restricted period lapses immediately upon a change of control. This grant was approved by the Board of Directors of King Pharmaceuticals, Inc. ("King") on August 2, 2006 as disclosed in the Current Report on Form 8-K filed by King on August 8, 2006.